Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
CNY 7.23
(-3.73%)
CNY 7.23
(-3.73%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 527.57 Million CNY | 162.81% |
| 2022 | 200.74 Million CNY | -33.06% |
| 2021 | 299.87 Million CNY | 23.0% |
| 2020 | 243.8 Million CNY | -28.52% |
| 2019 | 341.09 Million CNY | -53.21% |
| 2018 | 729.05 Million CNY | 238.63% |
| 2017 | 215.29 Million CNY | -70.5% |
| 2016 | 729.76 Million CNY | -44.26% |
| 2015 | 1.3 Billion CNY | 64.52% |
| 2014 | 795.71 Million CNY | 17.32% |
| 2013 | 678.22 Million CNY | 74.39% |
| 2012 | 388.92 Million CNY | 29.91% |
| 2011 | 299.37 Million CNY | -34.02% |
| 2010 | 453.74 Million CNY | -27.37% |
| 2009 | 624.74 Million CNY | -15.31% |
| 2008 | 737.66 Million CNY | 0.37% |
| 2007 | 734.97 Million CNY | 6.34% |
| 2006 | 691.13 Million CNY | 26.99% |
| 2005 | 544.22 Million CNY | 13.35% |
| 2004 | 480.11 Million CNY | 21.87% |
| 2003 | 393.94 Million CNY | 91.68% |
| 2002 | 205.51 Million CNY | 163.62% |
| 2001 | 77.96 Million CNY | 76.76% |
| 2000 | 44.1 Million CNY | -52.47% |
| 1999 | 92.78 Million CNY | -62.86% |
| 1998 | 249.81 Million CNY | 286.09% |
| 1997 | 64.7 Million CNY | 25.51% |
| 1996 | 51.55 Million CNY | -30.22% |
| 1995 | 73.87 Million CNY | 213.84% |
| 1994 | 23.54 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 467 Million CNY | -11.48% |
| 2024 Q3 | 693.87 Million CNY | 33.05% |
| 2024 Q2 | 521.5 Million CNY | 11.67% |
| 2023 FY | 527.57 Million CNY | 162.81% |
| 2023 Q2 | 300.44 Million CNY | 50.21% |
| 2023 Q4 | 527.57 Million CNY | 42.91% |
| 2023 Q3 | 369.16 Million CNY | 22.87% |
| 2023 Q1 | 200.01 Million CNY | -0.36% |
| 2022 Q2 | 176.2 Million CNY | -41.65% |
| 2022 FY | 200.74 Million CNY | -33.06% |
| 2022 Q4 | 200.74 Million CNY | -62.02% |
| 2022 Q1 | 301.99 Million CNY | 0.71% |
| 2022 Q3 | 528.56 Million CNY | 199.98% |
| 2021 FY | 299.87 Million CNY | 23.0% |
| 2021 Q1 | 343.94 Million CNY | 41.08% |
| 2021 Q2 | 308.23 Million CNY | -10.38% |
| 2021 Q4 | 299.87 Million CNY | -7.2% |
| 2021 Q3 | 323.14 Million CNY | 4.84% |
| 2020 FY | 243.8 Million CNY | -28.52% |
| 2020 Q3 | 206.12 Million CNY | -65.48% |
| 2020 Q1 | 617.74 Million CNY | 81.1% |
| 2020 Q2 | 597.19 Million CNY | -3.33% |
| 2020 Q4 | 243.8 Million CNY | 18.28% |
| 2019 FY | 341.09 Million CNY | -53.21% |
| 2019 Q4 | 341.09 Million CNY | 4.41% |
| 2019 Q1 | 998.72 Million CNY | 36.99% |
| 2019 Q2 | 788.54 Million CNY | -21.04% |
| 2019 Q3 | 326.7 Million CNY | -58.57% |
| 2018 Q2 | 734.54 Million CNY | 221.42% |
| 2018 Q1 | 228.52 Million CNY | 6.15% |
| 2018 Q4 | 729.05 Million CNY | 20.41% |
| 2018 FY | 729.05 Million CNY | 238.63% |
| 2018 Q3 | 605.49 Million CNY | -17.57% |
| 2017 Q2 | 687.87 Million CNY | 12.54% |
| 2017 Q3 | 496.03 Million CNY | -27.89% |
| 2017 Q1 | 611.2 Million CNY | -16.25% |
| 2017 Q4 | 215.29 Million CNY | -56.6% |
| 2017 FY | 215.29 Million CNY | -70.5% |
| 2016 Q3 | 873.82 Million CNY | -37.71% |
| 2016 Q1 | 1.3 Billion CNY | -0.49% |
| 2016 Q2 | 1.4 Billion CNY | 7.68% |
| 2016 Q4 | 729.76 Million CNY | -16.49% |
| 2016 FY | 729.76 Million CNY | -44.26% |
| 2015 Q4 | 1.3 Billion CNY | 23.63% |
| 2015 Q2 | 923.79 Million CNY | 18.71% |
| 2015 FY | 1.3 Billion CNY | 64.52% |
| 2015 Q1 | 778.2 Million CNY | -2.2% |
| 2015 Q3 | 1.05 Billion CNY | 14.62% |
| 2014 Q2 | 798.1 Million CNY | 40.88% |
| 2014 Q4 | 795.71 Million CNY | -5.67% |
| 2014 Q3 | 843.5 Million CNY | 5.69% |
| 2014 Q1 | 566.53 Million CNY | -16.47% |
| 2014 FY | 795.71 Million CNY | 17.32% |
| 2013 Q2 | 517.99 Million CNY | 13.03% |
| 2013 FY | 678.22 Million CNY | 74.39% |
| 2013 Q4 | 678.22 Million CNY | 11.36% |
| 2013 Q1 | 458.26 Million CNY | 17.83% |
| 2013 Q3 | 609.01 Million CNY | 17.57% |
| 2012 FY | 388.92 Million CNY | 29.91% |
| 2012 Q4 | 388.92 Million CNY | 21.99% |
| 2012 Q3 | 318.81 Million CNY | 8.04% |
| 2012 Q2 | 295.09 Million CNY | -6.95% |
| 2012 Q1 | 317.13 Million CNY | 5.93% |
| 2011 FY | 299.37 Million CNY | -34.02% |
| 2011 Q2 | 555.37 Million CNY | 21.91% |
| 2011 Q3 | 457.83 Million CNY | -17.56% |
| 2011 Q4 | 299.37 Million CNY | -34.61% |
| 2011 Q1 | 455.57 Million CNY | 0.4% |
| 2010 FY | 453.74 Million CNY | -27.37% |
| 2010 Q1 | 601.54 Million CNY | -3.71% |
| 2010 Q2 | 545.76 Million CNY | -9.27% |
| 2010 Q3 | 508.07 Million CNY | -6.91% |
| 2010 Q4 | 453.74 Million CNY | -10.69% |
| 2009 Q4 | 624.74 Million CNY | -10.44% |
| 2009 Q3 | 697.56 Million CNY | -6.51% |
| 2009 Q1 | 737.91 Million CNY | 0.03% |
| 2009 Q2 | 746.16 Million CNY | 1.12% |
| 2009 FY | 624.74 Million CNY | -15.31% |
| 2008 FY | 737.66 Million CNY | 0.37% |
| 2008 Q1 | 742.67 Million CNY | 1.05% |
| 2008 Q2 | 750.05 Million CNY | 0.99% |
| 2008 Q3 | 750.86 Million CNY | 0.11% |
| 2008 Q4 | 737.66 Million CNY | -1.76% |
| 2007 Q4 | 734.97 Million CNY | -3.11% |
| 2007 Q2 | 738.77 Million CNY | 1.23% |
| 2007 FY | 734.97 Million CNY | 6.34% |
| 2007 Q1 | 729.79 Million CNY | 5.59% |
| 2007 Q3 | 758.52 Million CNY | 2.67% |
| 2006 Q3 | 648.25 Million CNY | 4.78% |
| 2006 Q4 | 691.13 Million CNY | 6.61% |
| 2006 Q1 | 611.29 Million CNY | 12.32% |
| 2006 Q2 | 618.68 Million CNY | 1.21% |
| 2006 FY | 691.13 Million CNY | 26.99% |
| 2005 Q4 | 544.22 Million CNY | -2.92% |
| 2005 Q3 | 560.59 Million CNY | 9.53% |
| 2005 Q2 | 511.81 Million CNY | 9.32% |
| 2005 Q1 | 468.18 Million CNY | -2.49% |
| 2005 FY | 544.22 Million CNY | 13.35% |
| 2004 Q2 | 451.61 Million CNY | 0.25% |
| 2004 Q3 | 454.21 Million CNY | 0.57% |
| 2004 Q4 | 480.11 Million CNY | 5.7% |
| 2004 FY | 480.11 Million CNY | 21.87% |
| 2004 Q1 | 450.49 Million CNY | 14.35% |
| 2003 Q2 | 258.99 Million CNY | 0.21% |
| 2003 Q4 | 393.94 Million CNY | 53.44% |
| 2003 Q3 | 256.74 Million CNY | -0.87% |
| 2003 FY | 393.94 Million CNY | 91.68% |
| 2003 Q1 | 258.44 Million CNY | 25.75% |
| 2002 Q4 | 205.51 Million CNY | 95.92% |
| 2002 Q1 | 1.45 Billion CNY | 1767.7% |
| 2002 FY | 205.51 Million CNY | 163.62% |
| 2002 Q3 | 104.89 Million CNY | 93.39% |
| 2002 Q2 | 54.24 Million CNY | -96.27% |
| 2001 FY | 77.96 Million CNY | 76.76% |
| 2001 Q4 | 77.96 Million CNY | 0.0% |
| 2001 Q2 | 52.27 Million CNY | 0.0% |
| 2000 Q2 | 87.69 Million CNY | 0.0% |
| 2000 Q4 | 44.1 Million CNY | 0.0% |
| 2000 FY | 44.1 Million CNY | -52.47% |
| 1999 Q2 | 81.87 Million CNY | 0.0% |
| 1999 FY | 92.78 Million CNY | -62.86% |
| 1999 Q4 | 92.78 Million CNY | 0.0% |
| 1998 Q2 | 122.52 Million CNY | 0.0% |
| 1998 FY | 249.81 Million CNY | 286.09% |
| 1998 Q4 | 249.81 Million CNY | 0.0% |
| 1997 FY | 64.7 Million CNY | 25.51% |
| 1997 Q4 | 64.7 Million CNY | 0.0% |
| 1997 Q2 | 56.39 Million CNY | 0.0% |
| 1996 Q4 | 51.55 Million CNY | 0.0% |
| 1996 FY | 51.55 Million CNY | -30.22% |
| 1996 Q2 | 37.23 Million CNY | 0.0% |
| 1995 Q4 | 73.87 Million CNY | 0.0% |
| 1995 FY | 73.87 Million CNY | 213.84% |
| 1995 Q2 | 36.89 Million CNY | 0.0% |
| 1994 FY | 23.54 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 2.75 Billion CNY | 80.825% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.14 Billion CNY | 83.21% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.88 Billion CNY | 86.433% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 887.5 Million CNY | 40.556% |
| Aurora Optoelectronics Co.,Ltd. | 1.09 Billion CNY | 52.03% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 290.34 Million CNY | -81.709% |
| NanJing Pharmaceutical Company Limited | 20.95 Billion CNY | 97.483% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 1.12 Billion CNY | 52.918% |